Glioblastoma, is the most frequent malignant tumor of the Central Nervous System and, due to its heterogeneity and its high capacity for local invasion, in most cases it has a poor prognosis, despite current treatment protocols. One of the characteristics of the glioblastoma microenvironment is hypoxia, generated by rapid tumor growth. The invasive capacity of […]
On November 13, the first session will take place within the IV Progress Reports Valdecilla Program, which will feature presentations by Julia Garcia Reyero and Miriam Sánchez Escamilla. TItle: “MUTATIONAL PROFILE OF LYMPHOMAS B WITH PLASMOCELLULAR DIFFERENTIATION“ Speaker: Julia Garcia Reyero Julia Garcia Reyero has a degree in Medicine, from the Universidad San Pablo CEU […]
Researchers from the Neurodegenerative Diseases Group of IDIVAL have participated in the first study of genomic association (GWAs) in Parkinson's disease carried out in Spain. This is a study that has had the participation of 13 Spanish centers and has included 7,849 subjects with Parkinson's disease and healthy controls. The study has served to characterize […]
The central role of Mesenchymal Stem Cells (MSC) in Regenerative Medicine derives, in large part, from their ability to differentiate into different cell types. The induction of proliferation and differentiation to osteoblasts of MSCs forms the basis of bone regenerative therapies. Osteogenic differentiation of MSCs is a complex process regulated simultaneously by different signaling routes, […]
In accordance with the bases of the call published on the IDIVAL website, once the projects admitted for processing have been evaluated and two resignations have been received in the last 7 days established, funding is granted to the following projects: REFERENCE MAIN RESEARCHER GRANTED NVAL 19/05 Demetrio Pablo, Rosalía 10.200 € NVAL 19/22 Rueda […]
Recently, after the evaluation by international experts carried out by the Carlos III Health Institute, the 7th Call for Research Projects on HIV, Liver Diseases and Hemato-oncology of GILEAD Sciences has been resolved in which the “Liquid biopsy for the molecular diagnosis of DLBCL patients treated in clinical trials (GLD19 / 00041)” research project lead by […]
Next Thursday, October 31, the 2nd conference of the 4th edition of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and the IBBTEC will take place given by Dr. Germán Fajardo with the title “Panorama of medical education in Latin America and its possible collaboration with Europe, are we doing what […]
Project started with a kick-off meeting 9th -10th of October 2019 in Seinäjoki, Finland. Objectives of the meeting were to start a good and productive co-operation with the project partners by getting to know each other and to form a common understanding about the project goals and ways to achieve them. During the first day, […]
The candidacy of BIOBANCO VALDECILLA, has been selected for the organization of the XI CONGRESS OF THE NATIONAL BIOBANK NETWORK – SANTANDER 2020 From now on the countdown begins with the clear objective of making it a success both for your organization, as for its contents, speakers and participants. The Congress that will be held in […]
Date: Thursday 11/28/2019 Last day to apply: Monday 25/11/2019 Hours: from 9:00 a.m. to 1:00 p.m. Number of places: maximum 15 people Place: IDIVAL building, 3rd floor, multipurpose room. Intended for: IDIVAL staff Objective: Learn the protocol of action in case of accident in the company. Duration: 4 hours Teacher qualification: Doctor or DUE of […]
